Chargement…
596 entreprises que nous couvrons, dont 361 notées
Toutes les entreprises d’ici passées par les mêmes cinq vérifications sur la croissance et la génération de trésorerie. Cela décrit le sous-secteur tel qu’il publie aujourd’hui — pas laquelle de ces valeurs acheter.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | 133,5B $US | 526,82 $US | 30,68 | 12,6B $US | 35,0 % |
| MRNA | Moderna, Inc. | D- | 81,2B $US | 203,44 $US | — | 2,2B $US | -141,4 % |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | 80,1B $US | 750,43 $US | 18,54 | 15,5B $US | 27,9 % |
| LGVN | LONGEVERON INC. | F- | 76,2B $US | 2,71 $US | — | 1,2M $US | -1 977,6 % |
| ARGX | ARGENX SE | non notée | 60,1B $US | 970,42 $US | 49,59 | — | — |
| RVMD | Revolution Medicines, Inc. | F | 43,8B $US | 204,57 $US | — | 0,00 $US | — |
| ONC | BEONE MEDICINES LTD. | A+ | 41,6B $US | 365,49 $US | 65,38 | 6,1B $US | 10,7 % |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | A+ | 34B $US | 254,04 $US | 128,95 | 3,7B $US | 19,7 % |
| RPRX | Royalty Pharma plc | B+ | 32,4B $US | 58,22 $US | 30,97 | 2,5B $US | 32,1 % |
| NCNA | NUCANA PLC | non notée | 26,6B $US | 1,28 $US | — | — | — |
| ROIV | ROIVANT SCIENCES LTD. | F- | 26,4B $US | 36,51 $US | — | 7,5M $US | -3 535,0 % |
| INSM | INSMED INC | C- | 25,3B $US | 115,65 $US | — | 1,1B $US | -76,9 % |
| BNTX | BioNTech SE | D | 24,8B $US | 98,54 $US | — | 3B $US | -42,9 % |
| INCY | INCYTE CORPORATION | A+ | 24,6B $US | 123,25 $US | 17,41 | 5,4B $US | 26,7 % |
| AKTX | Akari Therapeutics, Plc | non notée | 15,4B $US | 9,86 $US | — | — | — |
| JAZZ | Jazz Pharmaceuticals plc | A+ | 15,1B $US | 232,46 $US | 15,89 | 4,6B $US | 20,4 % |
| EXEL | Exelixis Inc | A+ | 14,5B $US | 58,66 $US | 18,45 | 2,4B $US | 35,3 % |
| ASND | Ascendis Pharma A/S | D | 14,1B $US | 228,11 $US | — | 1,2B $US | -21,8 % |
| SMMT | Summit Therapeutics Inc. | F | 13,1B $US | 16,37 $US | — | 0,00 $US | — |
| BBIO | BridgeBio Pharma, Inc. | B | 12,9B $US | 65,94 $US | — | 713,1M $US | -98,5 % |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | 12,7B $US | 111,54 $US | 32,52 | 1,7B $US | 24,9 % |
| CORT | CORCEPT THERAPEUTICS INC | C | 12,4B $US | 114,79 $US | 273,31 | 830,8M $US | 6,6 % |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C- | 11,8B $US | 508,58 $US | — | 1,3B $US | -25,3 % |
| TWST | Twist Bioscience Corporation | C- | 11,7B $US | 186,06 $US | — | 431,8M $US | -31,7 % |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | 11,6B $US | 59,90 $US | 161,89 | 3,4B $US | 2,1 % |
| TECH | BIO-TECHNE Corp | B+ | 11,3B $US | 72,37 $US | 62,93 | 1,2B $US | 15,0 % |
| KRYS | Krystal Biotech, Inc. | A+ | 9,9B $US | 334,94 $US | 41,97 | 440,5M $US | 54,8 % |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | 9,7B $US | 185,93 $US | — | 776,6M $US | -24,7 % |
| IBRX | IMMUNITYBIO, INC. | B | 9,4B $US | 8,83 $US | — | 165,8M $US | -598,6 % |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | D- | 9,4B $US | 66,21 $US | — | 669,5M $US | -47,8 % |
| KYMR | KYMERA THERAPEUTICS, INC. | D- | 9,2B $US | 110,56 $US | — | 105M $US | -285,3 % |
| CYTK | CYTOKINETICS, INCORPORATED | F | 9,1B $US | 65,67 $US | — | 67,7M $US | -1 321,1 % |
| PTGX | Protagonist Therapeutics, Inc | A+ | 9,1B $US | 140,93 $US | 138,17 | 282M $US | 29,4 % |
| CAI | CARIS LIFE SCIENCES, INC. | A+ | 8,9B $US | 31,56 $US | 18,67 | 989,6M $US | 10,6 % |
| TGTX | TG THERAPEUTICS, INC. | A+ | 8,6B $US | 56,19 $US | 20,43 | 799,5M $US | 55,2 % |
| PCVX | VAXCYTE, INC. | non notée | 8,4B $US | 56,71 $US | — | — | — |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | 7,9B $US | 281,36 $US | — | 0,00 $US | — |
| ABVX | Abivax S.A. | non notée | 7,7B $US | 98,50 $US | — | — | — |
| IONS | Ionis Pharmaceuticals, Inc. | F- | 7,6B $US | 45,91 $US | — | 874,1M $US | -64,7 % |
| SYRE | SPYRE THERAPEUTICS, INC. | F | 7,5B $US | 84,70 $US | — | 0,00 $US | — |
| GPCR | Structure Therapeutics Inc. | non notée | 7B $US | 32,66 $US | — | — | — |
| IMVT | IMMUNOVANT, INC. | non notée | 6,9B $US | 33,45 $US | — | — | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | 6,6B $US | 95,72 $US | — | 239,9M $US | -85,6 % |
| BLTE | Belite Bio, Inc | non notée | 6,5B $US | 166,47 $US | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | 6,5B $US | 14,45 $US | — | 325M $US | -89,1 % |
| CGON | CG Oncology, Inc. | D- | 6,3B $US | 70,56 $US | — | 6,2M $US | -3 602,7 % |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | A+ | 6,2B $US | 310,37 $US | 32,98 | 290,5M $US | 67,9 % |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F | 5,8B $US | 47,73 $US | — | 0,00 $US | — |
| KOD | KODIAK SCIENCES INC. | non notée | 5,7B $US | 91,15 $US | — | — | — |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | 5,7B $US | 87,58 $US | — | 618,1M $US | -139,2 % |
| GOSS | GOSSAMER BIO, INC. | B | 5,7B $US | 11,61 $US | — | 53,3M $US | -235,0 % |
| TVTX | TRAVERE THERAPEUTICS, INC. | D- | 5,7B $US | 60,01 $US | — | 591,3M $US | -7,4 % |
| COGT | Cogent Biosciences, Inc. | non notée | 5,5B $US | 31,66 $US | — | — | — |
| ORKA | Oruka Therapeutics, Inc. | non notée | 5,4B $US | 82,11 $US | — | — | — |
| PTCT | PTC Therapeutics, Inc. | D | 5,4B $US | 64,96 $US | — | 1B $US | -3,8 % |
| CRSP | CRISPR THERAPEUTICS AG | F- | 5,4B $US | 56,03 $US | — | 13,4M $US | -3 368,7 % |
| DFTX | Definium Therapeutics, Inc. | non notée | 5,1B $US | 38,22 $US | — | — | — |
| ERAS | Erasca, Inc. | non notée | 5B $US | 14,22 $US | — | — | — |
| MANE | Veradermics, Inc | non notée | 4,9B $US | 117,80 $US | — | — | — |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | F- | 4,9B $US | 87,18 $US | — | 2M $US | -9 442,3 % |
| ABCL | AbCellera Biologics Inc. | D- | 4,5B $US | 14,83 $US | — | 66,2M $US | -248,8 % |
| EWTX | Edgewise Therapeutics, Inc. | non notée | 4,3B $US | 39,19 $US | — | — | — |
| TNGX | Tango Therapeutics, Inc. | F- | 4,1B $US | 24,45 $US | — | 53,8M $US | -229,9 % |
| RLAY | Relay Therapeutics, Inc. | C- | 4B $US | 18,38 $US | — | 10,4M $US | -2 763,6 % |
| TLX | Telix Pharmaceuticals Limited | D- | 3,8B $US | 11,34 $US | — | 803,8M $US | -0,9 % |
| CELC | CELCUITY INC. | non notée | 3,8B $US | 77,30 $US | — | — | — |
| VKTX | Viking Therapeutics, Inc. | F | 3,7B $US | 31,81 $US | — | 0,00 $US | — |
| IDYA | IDEAYA Biosciences, Inc. | D- | 3,6B $US | 37,82 $US | — | 234,1M $US | -74,8 % |
| XENE | XENON PHARMACEUTICALS INC. | F | 3,6B $US | 37,27 $US | — | 0,00 $US | — |
| ACAD | ACADIA PHARMACEUTICALS INC. | A+ | 3,5B $US | 20,22 $US | 9,07 | 1,1B $US | 33,4 % |
| LEGN | Legend Biotech Corp | C- | 3,5B $US | 18,81 $US | — | 1B $US | -24,6 % |
| DBVT | DBV Technologies S.A. | F- | 3,4B $US | 11,57 $US | — | 5M $US | -3 506,5 % |
| ELVN | ENLIVEN THERAPEUTICS, INC. | non notée | 3,4B $US | 46,51 $US | — | — | — |
| TARS | TARSUS PHARMACEUTICALS, INC. | A | 3,4B $US | 76,79 $US | — | 606,3M $US | -7,7 % |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | A | 3,4B $US | 26,74 $US | 127,33 | 464M $US | 6,1 % |
| DNLI | Denali Therapeutics Inc. | F- | 3,3B $US | 20,82 $US | — | 3,6M $US | -14 191,2 % |
| RCUS | Arcus Biosciences, Inc. | D- | 3,3B $US | 25,64 $US | — | 117M $US | -393,2 % |
| DYN | Dyne Therapeutics, Inc. | non notée | 3B $US | 16,22 $US | — | — | — |
| PGEN | PRECIGEN, INC. | F- | 2,9B $US | 8,06 $US | — | 9,7M $US | -1 628,5 % |
| NAMS | NewAmsterdam Pharma Company N.V. | F- | 2,8B $US | 23,82 $US | — | 7,1M $US | -3 644,2 % |
| MBX | MBX Biosciences, Inc. | non notée | 2,8B $US | 57,78 $US | — | — | — |
| BEAM | Beam Therapeutics Inc. | C- | 2,5B $US | 24,51 $US | — | 156M $US | -54,7 % |
| IRON | Disc Medicine, Inc. | non notée | 2,5B $US | 65,89 $US | — | — | — |
| IMNM | Immunome, Inc. | F | 2,5B $US | 21,88 $US | — | 0,00 $US | — |
| CLDX | Celldex Therapeutics, Inc. | F- | 2,5B $US | 31,62 $US | — | 158K $US | -190 220,9 % |
| NRIX | NURIX THERAPEUTICS, INC. | F- | 2,5B $US | 23,69 $US | — | 36,8M $US | -928,4 % |
| VERA | Vera Therapeutics, Inc. | non notée | 2,3B $US | 32,38 $US | — | — | — |
| SLS | SELLAS Life Sciences Group, Inc. | non notée | 2,3B $US | 11,51 $US | — | — | — |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | A+ | 2,3B $US | 39,28 $US | 12,71 | 959,9M $US | 18,9 % |
| VRDN | Viridian Therapeutics, Inc./DE | D- | 2,3B $US | 20,00 $US | — | 71,1M $US | -544,1 % |
| ADMA | ADMA BIOLOGICS, INC. | A+ | 2,2B $US | 9,97 $US | 14,24 | 512,3M $US | 33,0 % |
| GMAB | Genmab A/S | A+ | 2,2B $US | 35,57 $US | 2,31 | 3,7B $US | 25,9 % |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | 2,2B $US | 16,43 $US | 7,17 | 311,5M $US | 100,8 % |
| MLYS | MINERALYS THERAPEUTICS, INC. | non notée | 2,2B $US | 24,44 $US | — | — | — |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | 2,2B $US | 4,03 $US | — | 54,9M $US | -945,9 % |
| VCEL | VERICEL CORPORATION | A | 2,1B $US | 40,63 $US | 86,44 | 306,3M $US | 7,9 % |
| PHVS | Pharvaris N.V. | non notée | 2,1B $US | 31,71 $US | — | — | — |
| TRVI | Trevi Therapeutics, Inc. | non notée | 2,1B $US | 14,42 $US | — | — | — |
| NKTR | Nektar Therapeutics | F- | 2B $US | 59,31 $US | — | 54,6M $US | -287,8 % |
| BHVN | Biohaven Ltd. | non notée | 2B $US | 13,30 $US | — | — | — |
| PVLA | Palvella Therapeutics, Inc. | non notée | 2B $US | 139,07 $US | — | — | — |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | 2B $US | 33,30 $US | — | 98,3M $US | -418,2 % |
| GENB | Generate Biomedicines, Inc. | non notée | 2B $US | 15,42 $US | — | — | — |
| URGN | UroGen Pharma Ltd. | C | 2B $US | 40,44 $US | — | 188,7M $US | -51,7 % |
| NUVB | Nuvation Bio Inc. | C- | 2B $US | 5,62 $US | — | 169,9M $US | -88,2 % |
| SRPT | SAREPTA THERAPEUTICS, INC. | B- | 2B $US | 18,65 $US | — | 2B $US | -6,9 % |
| LKFT | GALAPAGOS NV | B | 1,9B $US | 29,56 $US | 5,34 | 1,3B $US | 28,9 % |
| MESO | MESOBLAST LIMITED | C- | 1,9B $US | 14,89 $US | — | 65,4M $US | -156,2 % |
| ZYME | ZYMEWORKS INC. | F- | 1,9B $US | 27,14 $US | — | 37,1M $US | -404,0 % |
| FTRE | FORTREA HOLDINGS INC. | C | 1,9B $US | 19,76 $US | — | 2,7B $US | -3,2 % |
| XNCR | Xencor, Inc | F- | 1,9B $US | 24,99 $US | — | 105M $US | -155,6 % |
| SEPN | Septerna, Inc. | B | 1,8B $US | 39,11 $US | — | 98,9M $US | -24,5 % |
| VIR | Vir Biotechnology, Inc. | C- | 1,8B $US | 10,66 $US | — | 303,2M $US | -83,0 % |
| NVAX | NOVAVAX INC | D | 1,8B $US | 10,83 $US | — | 413,8M $US | -59,9 % |
| ZBIO | Zenas BioPharma, Inc. | F- | 1,7B $US | 26,74 $US | — | 10M $US | -4 843,8 % |
| ABSI | ABSCI CORP | F- | 1,7B $US | 10,13 $US | — | 1,6M $US | -7 756,4 % |
| OCUL | OCULAR THERAPEUTIX, INC | F- | 1,7B $US | 7,86 $US | — | 52,1M $US | -579,1 % |
| NTLA | INTELLIA THERAPEUTICS, INC. | C- | 1,7B $US | 12,04 $US | — | 59,5M $US | -672,2 % |
| STOK | Stoke Therapeutics, Inc. | F- | 1,7B $US | 25,90 $US | — | 27,6M $US | -753,6 % |
| TSHA | Taysha Gene Therapies, Inc. | F- | 1,6B $US | 5,00 $US | — | 5,5M $US | -2 728,0 % |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | 1,6B $US | 18,24 $US | — | 252,3M $US | -87,5 % |
| RAPP | Rapport Therapeutics, Inc. | non notée | 1,6B $US | 33,07 $US | — | — | — |
| IMCR | Immunocore Holdings plc | C- | 1,6B $US | 30,76 $US | — | 430,8M $US | -4,2 % |
| QURE | uniQure N.V. | C- | 1,5B $US | 24,51 $US | — | 18,1M $US | -1 154,4 % |
| INBX | INHIBRX BIOSCIENCES, INC. | D- | 1,5B $US | 104,83 $US | — | 1,3M $US | -10 629,3 % |
| GHRS | GH Research PLC | non notée | 1,5B $US | 24,70 $US | — | — | — |
| NBTX | Nanobiotix S.A. | C- | 1,5B $US | 31,59 $US | — | 37,1M $US | -73,5 % |
| INVA | INNOVIVA, INC. | B+ | 1,5B $US | 21,12 $US | 5,14 | 440M $US | 81,2 % |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | 1,5B $US | 15,32 $US | — | 717,2M $US | -81,7 % |
| ANAB | ANAPTYSBIO, INC. | B+ | 1,5B $US | 50,32 $US | 8,77 | 237,6M $US | 82,4 % |
| MAZE | MAZE THERAPEUTICS, INC. | F- | 1,5B $US | 27,02 $US | — | 167,5M $US | -79,8 % |
| AVBP | ARRIVENT BIOPHARMA, INC. | non notée | 1,5B $US | 29,54 $US | — | — | — |
| OMER | OMEROS CORP | non notée | 1,4B $US | 19,27 $US | 11,20 | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | F- | 1,4B $US | 14,86 $US | — | 85,6M $US | -216,5 % |
| ORIC | ORIC PHARMACEUTICALS, INC. | non notée | 1,4B $US | 13,35 $US | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | non notée | 1,3B $US | 15,20 $US | — | — | — |
| TYRA | Tyra Biosciences, Inc. | non notée | 1,3B $US | 21,98 $US | — | — | — |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | non notée | 1,3B $US | 35,97 $US | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | non notée | 1,3B $US | 20,65 $US | — | — | — |
| BCAX | Bicara Therapeutics Inc. | non notée | 1,2B $US | 18,54 $US | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | non notée | 1,2B $US | 12,99 $US | — | — | — |
| LBRX | LB Pharmaceuticals Inc | non notée | 1,2B $US | 37,23 $US | — | — | — |
| IMTX | Immatics N.V. | non notée | 1,1B $US | 8,56 $US | — | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | 1,1B $US | 7,65 $US | — | 208,8M $US | -37,1 % |
| VOR | Vor Biopharma Inc. | non notée | 1,1B $US | 18,33 $US | 0,10 | — | — |
| MNKD | MANNKIND CORP | C | 1,1B $US | 3,34 $US | — | 393,6M $US | -11,1 % |
| MGTX | MeiraGTx Holdings plc | A | 1,1B $US | 11,13 $US | 15,67 | 397,5M $US | 19,9 % |
| SVRA | Savara Inc | non notée | 1B $US | 5,10 $US | — | — | — |
| ANRO | Alto Neuroscience, Inc. | non notée | 1B $US | 26,58 $US | — | — | — |
| JANX | Janux Therapeutics, Inc. | B- | 1B $US | 16,95 $US | — | 24M $US | -427,5 % |
| AKTS | Aktis Oncology, Inc. | non notée | 1B $US | 19,72 $US | — | — | — |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | 1B $US | 14,50 $US | — | 92M $US | -194,7 % |
| GLUE | Monte Rosa Therapeutics, Inc. | D- | 1B $US | 11,75 $US | — | 28,7M $US | -560,8 % |
| APMD | Apnimed, Inc. | non notée | 996,6M $US | 23,94 $US | — | — | — |
| CRVS | Corvus Pharmaceuticals, Inc. | non notée | 986,7M $US | 11,73 $US | — | — | — |
| CGEM | CULLINAN THERAPEUTICS, INC. | non notée | 980,8M $US | 15,24 $US | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | non notée | 973,6M $US | 11,44 $US | — | — | — |
| KURA | KURA ONCOLOGY, INC. | D- | 960,8M $US | 10,80 $US | — | 77,2M $US | -384,3 % |
| ABUS | Arbutus Biopharma Corp | C+ | 926,9M $US | 4,69 $US | 5,93 | 181,7M $US | 84,2 % |
| ALMS | Alumis Inc. | D- | 920M $US | 7,28 $US | — | 7,4M $US | -5 933,5 % |
| RIGL | RIGEL PHARMACEUTICALS, INC. | B+ | 913,1M $US | 48,88 $US | 2,90 | 276,8M $US | 116,3 % |
| JAGX | JAGUAR HEALTH, INC. | B | 906,4M $US | 5,29 $US | — | 27,8M $US | -132,2 % |
| JBIO | Jade Biosciences, Inc. | non notée | 903,1M $US | 14,20 $US | — | — | — |
| TBPH | Theravance Biopharma, Inc. | B | 884,2M $US | 17,03 $US | 16,86 | 104,3M $US | 51,6 % |
| SANA | Sana Biotechnology, Inc. | non notée | 874,1M $US | 2,92 $US | — | — | — |
| SGP | SpyGlass Pharma, Inc. | non notée | 851,3M $US | 25,45 $US | — | — | — |
| ARDX | ARDELYX, INC. | B- | 843,5M $US | 3,39 $US | — | 450,9M $US | -12,4 % |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C- | 838,7M $US | 1,89 $US | — | 41,5M $US | -147,4 % |
| AVTX | AVALO THERAPEUTICS, INC. | F- | 834,2M $US | 15,56 $US | — | 59K $US | -170 055,9 % |
| CADL | CANDEL THERAPEUTICS, INC. | non notée | 832,5M $US | 10,88 $US | — | — | — |
| ANNX | ANNEXON, INC. | non notée | 819,1M $US | 4,15 $US | — | — | — |
| GYRE | Gyre Therapeutics, Inc. | D- | 817,4M $US | 7,33 $US | — | 119,4M $US | -23,6 % |
| GERN | GERON CORP | non notée | 796,7M $US | 1,24 $US | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | non notée | 791,8M $US | 7,70 $US | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | 791M $US | 12,64 $US | — | 0,00 $US | — |
| ACRS | Aclaris Therapeutics, Inc. | D- | 777,2M $US | 5,28 $US | — | 8,2M $US | -921,5 % |
| SLDB | Solid Biosciences Inc. | non notée | 768,8M $US | 7,17 $US | — | — | — |
| IMMX | IMMIX BIOPHARMA, INC. | non notée | 752,6M $US | 10,52 $US | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | non notée | 748,1M $US | 8,55 $US | — | — | — |
| VSTM | Verastem, Inc. | D- | 716,4M $US | 7,91 $US | — | 87,5M $US | -231,6 % |
| WVE | WAVE LIFE SCIENCES LTD. | F- | 715,3M $US | 3,63 $US | — | 42,7M $US | -473,9 % |
| PHAR | Pharming Group N.V. | A | 714M $US | 10,18 $US | 254,38 | 376,1M $US | 0,8 % |
| OABI | OMNIAB, INC. | D- | 689,2M $US | 4,74 $US | — | 38,5M $US | -115,1 % |
| IMMP | Immutep Limited | D- | 683,5M $US | 4,68 $US | — | 7,2M $US | -594,6 % |
| MDXG | MiMedx Group, Inc. | C | 680,7M $US | 4,67 $US | 116,75 | 355,2M $US | 1,8 % |
| ZVRA | Zevra Therapeutics, Inc. | A+ | 672,8M $US | 11,33 $US | 12,32 | 136,1M $US | 42,8 % |
| NVCT | Nuvectis Pharma, Inc. | non notée | 669,9M $US | 20,56 $US | — | — | — |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | D- | 663,8M $US | 11,97 $US | — | 111,9M $US | -260,0 % |
| CLYM | CLIMB BIO, INC. | non notée | 661,7M $US | 11,52 $US | — | — | — |
| STTK | Shattuck Labs, Inc. | C- | 656,4M $US | 6,54 $US | — | 1M $US | -5 256,8 % |
| AURA | Aura Biosciences, Inc. | non notée | 638,3M $US | 6,16 $US | — | — | — |
| IVA | Inventiva S.A. | F | 636,7M $US | 3,30 $US | — | 5,1M $US | -7 899,6 % |
| CRMD | CORMEDIX INC. | A+ | 618,9M $US | 7,94 $US | 3,87 | 462,2M $US | 40,5 % |
| IBO | Impact BioMedical, INC. | A | 600M $US | 5,57 $US | 6,32 | 35K $US | 2 254,3 % |
| CTMX | CytomX Therapeutics, Inc. | F- | 597M $US | 2,74 $US | — | 18,3M $US | -435,2 % |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | 596,6M $US | 7,38 $US | — | 239,7M $US | -41,3 % |
| ALT | ALTIMMUNE, INC. | D- | 575,8M $US | 2,96 $US | — | 41K $US | -223 804,9 % |
| NGNE | Neurogene Inc. | F | 568,3M $US | 28,40 $US | — | 0,00 $US | — |
| PRME | Prime Medicine, Inc. | C- | 564,1M $US | 3,11 $US | — | 4,6M $US | -4 056,4 % |
| ALLO | Allogene Therapeutics, Inc. | B- | 558M $US | 1,62 $US | — | 6,8M $US | -2 419,5 % |
| CBIO | CRESCENT BIOPHARMA, INC. | D- | 548,6M $US | 14,77 $US | — | 10,8M $US | -885,5 % |
| YDES | YD Bio Limited | D | 547,9M $US | 7,74 $US | — | 596,8K $US | -1 392,6 % |
| MNPR | Monopar Therapeutics Inc. | F | 537,1M $US | 80,02 $US | — | 0,00 $US | — |
| VALN | Valneva SE | D- | 534,9M $US | 6,17 $US | — | 177,9M $US | -73,7 % |
| COAG | Hemab Therapeutics Holdings, Inc. | non notée | 509,9M $US | 32,67 $US | — | — | — |
| SLN | Silence Therapeutics plc | C- | 509,3M $US | 10,78 $US | — | 615K $US | -9 748,5 % |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | non notée | 507,4M $US | 2,39 $US | — | — | — |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | 505,4M $US | 9,79 $US | 18,83 | 231,2M $US | 11,6 % |
| ANL | Adlai Nortye Ltd. | C | 502,2M $US | 15,71 $US | — | 5M $US | -710,6 % |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | 498,3M $US | 8,57 $US | — | 0,00 $US | — |
| PBLS | Parabilis Medicines, Inc. | non notée | 496M $US | 31,89 $US | — | — | — |
| AUTL | Autolus Therapeutics plc | C- | 492,4M $US | 1,85 $US | — | 117,4M $US | -238,7 % |
| RGNX | REGENXBIO Inc. | D- | 490,8M $US | 7,44 $US | — | 174,5M $US | -112,6 % |
| ARVN | ARVINAS, INC. | B | 490,7M $US | 7,51 $US | 31,27 | 316,7M $US | 2,9 % |
| OCS | Oculis Holding AG | non notée | 477,5M $US | 9,14 $US | — | — | — |
| ASMB | Assembly Biosciences, Inc. | B- | 477,5M $US | 23,45 $US | 22,99 | 72,3M $US | -0,1 % |
| TECX | TECTONIC THERAPEUTIC, INC. | non notée | 455,1M $US | 23,28 $US | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | C- | 451M $US | 8,79 $US | — | 54,5M $US | -80,7 % |
| AGEN | AGENUS INC | C | 444,8M $US | 9,88 $US | 3,83 | 132,7M $US | 69,3 % |
| DMAC | DiaMedica Therapeutics Inc. | non notée | 443,3M $US | 8,22 $US | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | D- | 438,6M $US | 4,41 $US | — | 116,9M $US | -184,2 % |
| MPLT | MapLight Therapeutics, Inc. | non notée | 429,5M $US | 10,12 $US | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | non notée | 429M $US | 7,92 $US | — | — | — |
| KYTX | Kyverna Therapeutics, Inc. | non notée | 423,6M $US | 6,85 $US | — | — | — |
| AVLN | Avalyn Pharma Inc. | non notée | 422M $US | 27,19 $US | — | — | — |
| AVIR | Atea Pharmaceuticals, Inc. | non notée | 413,9M $US | 5,16 $US | — | — | — |
| IRD | Opus Genetics, Inc. | F- | 411M $US | 4,94 $US | — | 9,9M $US | -1 091,8 % |
| ODTX | Odyssey Therapeutics, Inc. | non notée | 405,4M $US | 22,48 $US | — | — | — |
| TTRX | Turn Therapeutics Inc. | non notée | 402,7M $US | 13,52 $US | — | — | — |
| SGMT | Sagimet Biosciences Inc. | non notée | 399,8M $US | 9,32 $US | — | — | — |
| EDIT | EDITAS MEDICINE, INC. | B- | 398,5M $US | 2,60 $US | — | 47M $US | -157,3 % |
| RLMD | RELMADA THERAPEUTICS, INC. | non notée | 397,9M $US | 3,73 $US | — | — | — |
| RZLT | REZOLUTE, INC. | non notée | 395,6M $US | 4,09 $US | — | — | — |
| GALT | GALECTIN THERAPEUTICS INC. | non notée | 394,3M $US | 3,91 $US | — | — | — |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | 389,1M $US | 13,69 $US | — | 29,4M $US | -317,6 % |
| CCCC | C4 Therapeutics, Inc. | C- | 383,8M $US | 3,12 $US | — | 35M $US | -289,4 % |
| ZURA | ZURA BIO LIMITED | non notée | 383,3M $US | 4,00 $US | — | — | — |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | 378M $US | 10,78 $US | — | 59,2M $US | -5,5 % |
| SRZN | Surrozen, Inc./DE | D | 374,6M $US | 31,87 $US | — | 11,5M $US | -2 885,3 % |
| OCGN | OCUGEN, INC. | C | 369,6M $US | 1,09 $US | — | 4,6M $US | -1 786,3 % |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | 368,7M $US | 12,66 $US | — | 65,3M $US | -96,9 % |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | 365,7M $US | 6,09 $US | — | 32M $US | -184,6 % |
| SPTX | Seaport Therapeutics, Inc. | non notée | 358,8M $US | 18,77 $US | — | — | — |
| ARTV | Artiva Biotherapeutics, Inc. | F- | 344,4M $US | 7,05 $US | — | 0,00 $US | — |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | non notée | 341,6M $US | 49,67 $US | — | — | — |
| BNTC | Benitec Biopharma Inc. | D | 340,5M $US | 9,76 $US | — | 0,00 $US | — |
| CABA | CABALETTA BIO, INC. | non notée | 336,5M $US | 1,99 $US | — | — | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | non notée | 326,2M $US | 3,14 $US | — | — | — |
| IMUX | Immunic, Inc. | non notée | 325,1M $US | 8,94 $US | — | — | — |
| VERU | VERU INC. | non notée | 318,3M $US | 2,58 $US | — | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | 315,2M $US | 3,95 $US | — | 22,4M $US | -269,7 % |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | non notée | 314,3M $US | 3,92 $US | — | — | — |
| GTBP | GT BIOPHARMA, INC. | non notée | 306,7M $US | 6,80 $US | 18,37 | — | — |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | 303,5M $US | 5,02 $US | — | 215,7M $US | -127,4 % |
| EVMN | Evommune, Inc. | D- | 302,3M $US | 8,33 $US | — | 10M $US | -946,7 % |
| IPSC | Century Therapeutics, Inc. | B- | 298,8M $US | 1,65 $US | — | 109,2M $US | -100,6 % |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | 295,8M $US | 8,30 $US | — | 0,00 $US | — |
| EYPT | EyePoint, Inc. | F- | 295,7M $US | 3,43 $US | — | 2,8M $US | -10 994,7 % |
| ABEO | ABEONA THERAPEUTICS INC. | C- | 295,1M $US | 5,16 $US | — | 25,5M $US | -246,4 % |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | 293,9M $US | 3,23 $US | — | 0,00 $US | — |
| KARD | Kardigan, Inc. | non notée | 292,4M $US | 14,70 $US | — | — | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | 288,5M $US | 2,91 $US | — | 15,8M $US | -568,8 % |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | 287,1M $US | 14,54 $US | — | 0,00 $US | — |
| FATE | FATE THERAPEUTICS INC | D- | 285,2M $US | 2,38 $US | — | 6,5M $US | -1 941,1 % |
| UPB | UPSTREAM BIO, INC. | D- | 284,8M $US | 5,20 $US | — | 3,2M $US | -4 955,7 % |
| RCKT | Rocket Pharmaceuticals, Inc. | D | 284,3M $US | 2,59 $US | — | 0,00 $US | — |
| QTTB | Q32 Bio Inc. | B | 284M $US | 9,54 $US | 3,05 | 53,7M $US | 62,9 % |
| IKT | Inhibikase Therapeutics, Inc. | F | 282,6M $US | 2,03 $US | — | 0,00 $US | — |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | 282,3M $US | 3,70 $US | — | 0,00 $US | — |
| LXEO | Lexeo Therapeutics, Inc. | non notée | 280,6M $US | 3,42 $US | — | — | — |
| HELP | CYBIN INC. | non notée | 274,1M $US | 12,69 $US | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | non notée | 271,3M $US | 18,48 $US | — | — | — |
| IMRX | Immuneering Corporation | non notée | 267,8M $US | 4,14 $US | — | — | — |
| STRO | SUTRO BIOPHARMA, INC. | F | 267,5M $US | 16,13 $US | — | 45,7M $US | -395,2 % |
| LIMN | LIMINATUS PHARMA, INC. | non notée | 263,6M $US | 3,93 $US | — | — | — |
| ACIU | AC IMMUNE SA | F- | 263,5M $US | 2,59 $US | — | 4,3M $US | -1 207,8 % |
| BCYC | Bicycle Therapeutics plc | D- | 255,3M $US | 3,66 $US | — | 61,2M $US | -311,1 % |
| PALI | PALISADE BIO, INC. | C- | 251,8M $US | 1,45 $US | — | 500K $US | -6 388,2 % |
| IVVD | INVIVYD, INC. | C- | 250,6M $US | 0,85 $US | — | 58,4M $US | -183,9 % |
| CTNM | Contineum Therapeutics, Inc. | D | 250,4M $US | 10,84 $US | — | 0,00 $US | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | 245,4M $US | 3,91 $US | — | 3,5M $US | -3 065,9 % |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | 244,1M $US | 6,27 $US | — | 4,7M $US | -3 537,7 % |
| LCTX | Lineage Cell Therapeutics, Inc. | D- | 242,7M $US | 0,96 $US | — | 13,1M $US | -246,6 % |
| PYXS | Pyxis Oncology, Inc. | D- | 241,5M $US | 2,90 $US | — | 13,9M $US | -640,3 % |
| MGNX | MACROGENICS, INC. | C- | 239,5M $US | 3,76 $US | — | 167,7M $US | -8,7 % |
| LYEL | Lyell Immunopharma, Inc. | D- | 236M $US | 9,63 $US | — | 27K $US | -920 285,2 % |
| SION | SIONNA THERAPEUTICS, INC. | non notée | 232,8M $US | 5,15 $US | — | — | — |
| ZLAB | ZAI LAB LIMITED | C- | 229,6M $US | 25,92 $US | — | 449,6M $US | -41,9 % |
| KROS | Keros Therapeutics, Inc. | D- | 222,5M $US | 11,22 $US | — | 15M $US | -553,9 % |
| CGEN | COMPUGEN LTD | B+ | 221,3M $US | 2,34 $US | 6,16 | 74M $US | 47,6 % |
| AVXL | ANAVEX LIFE SCIENCES CORP. | non notée | 220,6M $US | 2,38 $US | — | — | — |
| RNAC | Cartesian Therapeutics, Inc. | F | 219M $US | 7,24 $US | — | 1,5M $US | -10 283,8 % |
| PLX | Protalix BioTherapeutics, Inc. | A+ | 217,5M $US | 2,70 $US | 11,74 | 80,6M $US | 23,5 % |
| MLEC | MOOLEC SCIENCE SA | D | 217,4M $US | 5,60 $US | — | 333,6M $US | -52,9 % |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | 213,2M $US | 3,74 $US | — | 0,00 $US | — |
| ALEC | Alector, Inc. | D- | 209,9M $US | 1,88 $US | — | 13,9M $US | -850,1 % |
| FHTX | Foghorn Therapeutics Inc. | B | 208,4M $US | 3,51 $US | — | 36,7M $US | -175,8 % |
| ELDN | Eledon Pharmaceuticals, Inc. | non notée | 204,4M $US | 2,52 $US | — | — | — |
| SLGL | Sol-Gel Technologies Ltd. | B | 200,8M $US | 72,08 $US | — | 1,8M $US | -341,3 % |
| CMPX | COMPASS THERAPEUTICS, INC. | F | 196,3M $US | 1,09 $US | — | 0,00 $US | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 195,1M $US | 4,69 $US | 1,14 | 2M $US | 8 743,5 % |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | 194,2M $US | 2,71 $US | — | 0,00 $US | — |
| ANTX | AN2 Therapeutics, Inc. | non notée | 192,5M $US | 5,10 $US | — | — | — |
| TARA | Protara Therapeutics, Inc. | non notée | 190,6M $US | 3,23 $US | — | — | — |
| ADAG | Adagene Inc. | C- | 189,8M $US | 3,21 $US | — | 7,7M $US | -229,6 % |
| ACOG | Alpha Cognition Inc. | D- | 189,5M $US | 8,70 $US | — | 15,3M $US | -153,6 % |
| NKTX | Nkarta, Inc. | D | 188,4M $US | 2,63 $US | — | 0,00 $US | — |
| CUE | Cue Biopharma, Inc. | D- | 186,3M $US | 25,64 $US | — | 37,7M $US | -435,8 % |
| ALXO | ALX ONCOLOGY HOLDINGS INC | non notée | 185,3M $US | 1,34 $US | — | — | — |
| INDP | Indaptus Therapeutics, Inc. | non notée | 183,4M $US | 2,86 $US | — | — | — |
| CHRS | Coherus Oncology, Inc. | B | 183,1M $US | 1,19 $US | — | 50,9M $US | -259,4 % |
| OVID | Ovid Therapeutics Inc. | C- | 180M $US | 2,54 $US | — | 1,6M $US | -2 178,9 % |
| MDWD | MEDIWOUND LTD. | F- | 177M $US | 13,79 $US | — | 11,9M $US | -170,1 % |
| PRQR | ProQR Therapeutics N.V. | C- | 174,4M $US | 1,66 $US | — | 20,9M $US | -229,7 % |
| MOLN | MOLECULAR PARTNERS AG | F- | 173,6M $US | 4,30 $US | — | 5,2M $US | -1 437,4 % |
| NAUT | Nautilus Biotechnology, Inc. | non notée | 173,1M $US | 1,36 $US | — | — | — |
| DTIL | PRECISION BIOSCIENCES INC | D- | 170,9M $US | 6,19 $US | — | 45,1M $US | -117,0 % |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | 165,9M $US | 9,67 $US | — | 29,1M $US | -548,6 % |
| VYGR | Voyager Therapeutics, Inc. | F- | 162,7M $US | 2,64 $US | — | 34,5M $US | -312,6 % |
| PEPG | PEPGEN INC. | non notée | 162,1M $US | 2,34 $US | — | — | — |
| ABOS | Acumen Pharmaceuticals, Inc. | non notée | 162M $US | 2,24 $US | — | — | — |
| NERV | Minerva Neurosciences, Inc. | F | 160,4M $US | 3,36 $US | — | 0,00 $US | — |
| KRSA | CYCLERION THERAPEUTICS, INC. | F- | 159,6M $US | 34,10 $US | — | 1,9M $US | -353,0 % |
| BRVE | Braveheart Bio, Inc. | non notée | 159,6M $US | 22,38 $US | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | non notée | 158,7M $US | 5,06 $US | — | — | — |
| NBP | NovaBridge Biosciences | non notée | 158,6M $US | 1,38 $US | — | — | — |
| NRSN | NeuroSense Therapeutics Ltd. | non notée | 154,3M $US | 4,74 $US | — | — | — |
| MENS | Jyong Biotech Ltd. | non notée | 153,6M $US | 2,02 $US | — | — | — |
| NGEN | NERVGEN PHARMA CORP. | non notée | 153,3M $US | 1,93 $US | — | — | — |
| IPHA | Innate Pharma SA | F- | 150,9M $US | 1,61 $US | — | 10,2M $US | -546,1 % |
| CDXS | Codexis, Inc. | D- | 148,4M $US | 1,36 $US | — | 77,7M $US | -39,6 % |
| HUMA | Humacyte, Inc. | C- | 148,3M $US | 0,53 $US | — | 2,1M $US | -4 560,8 % |
| CLLS | Cellectis S.A. | C- | 147,4M $US | 1,47 $US | — | 72,9M $US | -92,7 % |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | 144,5M $US | 0,80 $US | — | 4,9M $US | -618,0 % |
| RNA | Atrium Therapeutics, Inc. | non notée | 144M $US | 8,42 $US | — | — | — |
| KRRO | Korro Bio, Inc. | C- | 141,1M $US | 9,58 $US | — | 2,4M $US | -4 477,1 % |
| SPRB | Spruce Biosciences, Inc. | F | 136,6M $US | 47,53 $US | — | 0,00 $US | — |
| TNYA | Tenaya Therapeutics, Inc. | non notée | 134,6M $US | 0,60 $US | — | — | — |
| IFRX | InflaRx N.V. | F- | 134,5M $US | 1,86 $US | — | 33,4K $US | -155 582,1 % |
| CRBU | Caribou Biosciences, Inc. | D- | 133,5M $US | 1,25 $US | — | 10M $US | -1 030,4 % |
| MSLE | Satellos Bioscience Inc. | non notée | 132,9M $US | 8,60 $US | — | — | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | non notée | 132,7M $US | 3,57 $US | — | — | — |
| VOGX | Vogenx, Inc. | non notée | 132,6M $US | 24,32 $US | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | 131,6M $US | 2,07 $US | — | 0,00 $US | — |
| ENTX | ENTERA BIO LTD. | F | 131,6M $US | 2,68 $US | — | 0,00 $US | — |
| ENGN | enGene Therapeutics Inc. | non notée | 130,7M $US | 1,95 $US | — | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | non notée | 127,7M $US | 6,60 $US | — | — | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | non notée | 127,3M $US | 4,57 $US | — | — | — |
| NMRA | NEUMORA THERAPEUTICS, INC. | non notée | 127,3M $US | 0,68 $US | — | — | — |
| LENZ | LENZ THERAPEUTICS, INC. | D- | 121,6M $US | 3,87 $US | — | 19,1M $US | -660,1 % |
| SEER | SEER, INC. | D- | 119M $US | 2,15 $US | — | 14,2M $US | -478,0 % |
| COYA | Coya Therapeutics, Inc. | F- | 118,3M $US | 5,05 $US | — | 8M $US | -270,2 % |
| AARD | AARDVARK THERAPEUTICS, INC. | F | 118M $US | 5,39 $US | — | 0,00 $US | — |
| INO | INOVIO PHARMACEUTICALS, INC. | D | 115,8M $US | 1,12 $US | — | 0,00 $US | — |
| TLSA | Tiziana Life Sciences Ltd | non notée | 115,7M $US | 0,96 $US | — | — | — |
| VANI | Vivani Medical, Inc. | F | 111,9M $US | 1,24 $US | — | 0,00 $US | — |
| GNLX | GENELUX CORPORATION | F- | 110,9M $US | 2,45 $US | — | 8K $US | -444 950,0 % |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | D | 108M $US | 1,88 $US | — | 0,00 $US | — |
| CNXU | CONEXEU SCIENCES INC. | non notée | 105,4M $US | 3,74 $US | — | — | — |
| OKUR | ONKURE THERAPEUTICS, INC. | C | 105,1M $US | 2,60 $US | — | 0,00 $US | — |
| QNCX | Quince Therapeutics, Inc. | non notée | 104,3M $US | 31,64 $US | — | — | — |
| PLYX | Polaryx Therapeutics, Inc. | non notée | 102,7M $US | 2,06 $US | — | — | — |
| EQ | EQUILLIUM, INC. | C- | 102,4M $US | 1,62 $US | — | 41,1M $US | -43,8 % |
| MIST | Milestone Pharmaceuticals Inc. | non notée | 101,2M $US | 0,81 $US | — | — | — |
| PROK | ProKidney Corp. | F- | 100,6M $US | 1,64 $US | — | 818K $US | -10 288,4 % |
| NTRB | NUTRIBAND INC. | F- | 98,8M $US | 8,13 $US | — | 1,6M $US | -430,4 % |
| ANIX | ANIXA BIOSCIENCES, INC. | non notée | 98,7M $US | 2,84 $US | — | — | — |
| FTH | Faeth Therapeutics, Inc. | non notée | 97,9M $US | 28,11 $US | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | non notée | 97,3M $US | 10,85 $US | — | — | — |
| NRXS | NEURAXIS, INC. | D- | 96,7M $US | 7,70 $US | — | 5,3M $US | -144,4 % |
| PYPD | PolyPid Ltd | non notée | 95,4M $US | 5,24 $US | 2,51 | — | — |
| MNOV | MEDICINOVA, INC. | C- | 93,8M $US | 1,91 $US | — | 920,5K $US | -1 168,2 % |
| BMEA | Biomea Fusion, Inc. | non notée | 91,7M $US | 1,27 $US | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | 91,4M $US | 1,18 $US | — | 508K $US | -7 884,1 % |
| CGTX | Cognition Therapeutics, Inc. | non notée | 90,5M $US | 0,95 $US | — | — | — |
| RLYB | RALLYBIO CORPORATION | D | 89,5M $US | 16,86 $US | 3,43 | 646K $US | 7 051,2 % |
| ICCC | ImmuCell Corporation | A | 89,3M $US | 9,83 $US | 140,43 | 30,7M $US | 2,6 % |
| ACRV | Acrivon Therapeutics, Inc. | non notée | 89,1M $US | 2,08 $US | — | — | — |
| ONCY | ONCOLYTICS BIOTECH INC. | non notée | 85,2M $US | 0,67 $US | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 84,8M $US | 3,27 $US | — | 40K $US | -118 029,5 % |
| GUTS | Fractyl Health, Inc. | F- | 82,7M $US | 0,52 $US | — | 0,00 $US | — |
| PTHS | Pelthos Therapeutics Inc. | C- | 81,5M $US | 21,29 $US | — | 50,4M $US | -171,4 % |
| FBIO | Fortress Biotech, Inc. | B | 81,4M $US | 2,20 $US | 0,83 | 68,5M $US | 163,3 % |
| TELO | Telomir Pharmaceuticals, Inc. | non notée | 81,2M $US | 1,18 $US | — | — | — |
| ATRA | ATARA BIOTHERAPEUTICS, INC. | D | 81,1M $US | 8,08 $US | — | 6,2M $US | -269,4 % |
| ALDX | ALDEYRA THERAPEUTICS, INC. | non notée | 79,6M $US | 1,32 $US | — | — | — |
| VRCA | Verrica Pharmaceuticals Inc. | C- | 77,3M $US | 4,50 $US | — | 30,3M $US | -102,8 % |
| PMVP | PMV PHARMACEUTICALS, INC. | non notée | 77M $US | 1,44 $US | — | — | — |
| ATTO | Attovia Therapeutics, Inc. | non notée | 76M $US | 18,12 $US | — | — | — |
| IBIO | IBIO, INC. | D- | 75,6M $US | 1,18 $US | — | 100K $US | -33 044,0 % |
| LONA | LeonaBio, Inc. | non notée | 75,5M $US | 3,53 $US | — | — | — |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | 74,9M $US | 3,02 $US | — | 194K $US | -3 985,6 % |
| OSTX | OS THERAPIES INCORPORATED | non notée | 74,3M $US | 1,61 $US | — | — | — |
| GANX | GAIN THERAPEUTICS, INC | non notée | 73,8M $US | 1,69 $US | — | — | — |
| CING | Cingulate Inc. | non notée | 71,7M $US | 4,93 $US | — | — | — |
| OKYO | OKYO Pharma Limited | non notée | 71,4M $US | 1,36 $US | — | — | — |
| RNXT | RENOVORX, INC. | D- | 70,6M $US | 1,57 $US | — | 2M $US | -621,7 % |
| MAIA | MAIA Biotechnology, Inc. | F | 69,9M $US | 1,15 $US | — | 0,00 $US | — |
| SPRO | Spero Therapeutics, Inc. | C | 69,9M $US | 1,20 $US | 8,57 | 47M $US | 15,7 % |
| BSEM | BioStem Technologies, Inc. | D- | 69,2M $US | 3,88 $US | — | 34,6M $US | -81,8 % |
| TENX | TENAX THERAPEUTICS, INC. | F | 69M $US | 1,85 $US | — | 0,00 $US | — |
| KLRS | KALARIS THERAPEUTICS, INC. | non notée | 69M $US | 2,90 $US | — | — | — |
| RNTX | Rein Therapeutics, Inc. | F | 68,5M $US | 0,79 $US | — | 0,00 $US | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | 68,2M $US | 4,90 $US | — | 60,7M $US | -1,8 % |
| PLRX | PLIANT THERAPEUTICS, INC. | D | 66,9M $US | 1,08 $US | — | 0,00 $US | — |
| XBIT | XBIOTECH INC. | non notée | 66,5M $US | 2,18 $US | — | — | — |
| ALPS | ALPS GROUP INC | non notée | 65,7M $US | 0,40 $US | — | — | — |
| HYFT | MindWalk Holdings Corp. | C- | 64,7M $US | 1,39 $US | — | 19,8M $US | -43,6 % |
| LNAI | Lunai Bioworks Inc. | non notée | 64,2M $US | 1,77 $US | — | — | — |
| ACET | Adicet Bio, Inc. | non notée | 63,9M $US | 6,83 $US | — | — | — |
| CNTB | Connect Biopharma Holdings Limited | C- | 63M $US | 1,00 $US | — | 3M $US | -2 336,3 % |
| INKT | MiNK Therapeutics, Inc. | non notée | 62,3M $US | 12,20 $US | — | — | — |
| HYPD | HYPERION DEFI, INC. | D+ | 62,1M $US | 4,00 $US | — | 1,4M $US | 474,9 % |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | 61,4M $US | 15,21 $US | — | 0,00 $US | — |
| MREO | MEREO BIOPHARMA GROUP PLC | B | 59,5M $US | 0,37 $US | — | 500K $US | -5 619,8 % |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | 59,4M $US | 2,33 $US | — | 357,9K $US | -3 089,6 % |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C- | 58,6M $US | 0,31 $US | — | 151,2M $US | -22,5 % |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | 58,4M $US | 0,63 $US | — | -1,2M $US | 5 253,5 % |
| BOLD | BOUNDLESS BIO, INC. | non notée | 58,2M $US | 2,56 $US | — | — | — |
| EXOZ | EXOZYMES INC. | non notée | 58M $US | 6,25 $US | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | D- | 57,7M $US | 5,54 $US | — | 3,7M $US | -2 031,1 % |
| BLSM | BlossomHill Therapeutics, Inc. | non notée | 56,9M $US | 21,48 $US | — | — | — |
| SCTX | SCRIBE THERAPEUTICS INC. | non notée | 56,8M $US | 23,01 $US | — | — | — |
| SKYE | Skye Bioscience, Inc. | non notée | 56,3M $US | 1,59 $US | — | — | — |
| BCAB | BIOATLA, INC. | non notée | 56,1M $US | 1,74 $US | — | — | — |
| ANVS | Annovis Bio, Inc. | F | 55,8M $US | 1,31 $US | — | 0,00 $US | — |
| INMB | INMUNE BIO INC. | D- | 54,4M $US | 1,96 $US | — | 50K $US | -36 832,0 % |
| XLO | Xilio Therapeutics, Inc. | C- | 53,1M $US | 9,19 $US | — | 64,1M $US | -34,1 % |
| CLNN | Clene Inc. | D | 52,7M $US | 4,11 $US | — | 197K $US | -20 059,9 % |
| IMA | ImageneBio, Inc. | D- | 52,2M $US | 4,60 $US | — | 800K $US | -6 560,5 % |
| SER | Serina Therapeutics, Inc. | D | 50,8M $US | 2,00 $US | — | 130K $US | -16 288,5 % |
| CLGN | CollPlant Biotechnologies Ltd | B- | 50,2M $US | 3,92 $US | — | 2,4M $US | -484,6 % |
| ELTX | Elicio Therapeutics, Inc. | non notée | 48,6M $US | 1,85 $US | — | — | — |
| TIL | Instil Bio, Inc. | C- | 48,5M $US | 7,16 $US | — | 9M $US | -337,7 % |
| DWTX | Dogwood Therapeutics, Inc. | non notée | 45,6M $US | 1,34 $US | — | — | — |
| TVGN | Tevogen Inc. | non notée | 45,1M $US | 6,93 $US | — | — | — |
| FLNA | Filana Therapeutics, Inc. | non notée | 44,8M $US | 0,93 $US | — | — | — |
| GRCE | Grace Therapeutics, Inc. | non notée | 44,8M $US | 2,13 $US | — | — | — |
| CELU | Celularity Inc. | C | 44,6M $US | 1,38 $US | — | 19M $US | -374,7 % |
| HOWL | WEREWOLF THERAPEUTICS, INC. | non notée | 44M $US | 0,91 $US | — | — | — |
| CRVO | CervoMed Inc. | F- | 43,5M $US | 2,88 $US | — | 331,3K $US | -9 160,9 % |
| MGX | Metagenomi Therapeutics, Inc. | D- | 42,9M $US | 1,14 $US | — | 22,3M $US | -418,5 % |
| LITS | Lite Strategy, Inc. | D | 41,8M $US | 1,38 $US | — | 0,00 $US | — |
| PDSB | PDS Biotechnology Corp | non notée | 41,4M $US | 0,74 $US | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | 41,2M $US | 0,32 $US | — | 7,1M $US | -1 655,4 % |
| KAPA | KAIROS PHARMA, LTD. | non notée | 39,8M $US | 1,68 $US | — | — | — |
| ATHE | ALTERITY THERAPEUTICS LTD | non notée | 38,4M $US | 3,61 $US | — | — | — |
| ICU | SeaStar Medical Holding Corp | D- | 36,8M $US | 3,69 $US | — | 1,7M $US | -795,5 % |
| ATNM | ACTINIUM PHARMACEUTICALS, INC. | D+ | 36M $US | 1,15 $US | 3,18 | 90K $US | 12 564,4 % |
| NIKI | Niki BioSolutions, Inc. | non notée | 35M $US | 4,76 $US | — | — | — |
| MCRB | Seres Therapeutics, Inc. | D- | 34,8M $US | 3,50 $US | — | 1,9M $US | -1 192,9 % |
| EDSA | EDESA BIOTECH, INC. | non notée | 34,8M $US | 3,61 $US | — | — | — |
| NNVC | NANOVIRICIDES, INC. | F | 33,1M $US | 1,30 $US | — | 0,00 $US | — |
| BYSI | BeyondSpring Inc. | D | 31,8M $US | 0,77 $US | — | 0,00 $US | — |
| CVM | CEL-SCI CORPORATION | non notée | 31,1M $US | 1,77 $US | — | — | — |
| ATYR | aTYR PHARMA INC | F- | 30,2M $US | 0,31 $US | — | 190K $US | -32 003,7 % |
| ELAB | PMGC HOLDINGS INC. | D- | 30M $US | 3,70 $US | — | 2,6M $US | -523,0 % |
| CNTX | CONTEXT THERAPEUTICS INC. | non notée | 29,2M $US | 0,32 $US | — | — | — |
| IGC | IGC PHARMA, INC. | C- | 28M $US | 0,27 $US | — | 1,3M $US | -560,3 % |
| ABVC | ABVC BioPharma, Inc. | D- | 28M $US | 1,05 $US | — | 296K $US | -2 400,9 % |
| KYNB | KYNTRA BIO, INC. | F | 27,7M $US | 6,84 $US | 0,15 | 4,6M $US | 3 967,8 % |
| EVAX | Evaxion A/S | B- | 27,3M $US | 3,27 $US | — | 7,5M $US | -102,4 % |
| CALC | CalciMedica, Inc. | non notée | 26,3M $US | 1,60 $US | — | — | — |
| APRE | Aprea Therapeutics, Inc. | non notée | 26M $US | 0,76 $US | — | — | — |
| APLM | Apollomics Inc. | B | 25,8M $US | 23,40 $US | — | 8,5M $US | -128,7 % |
| NRXP | NRX Pharmaceuticals, Inc. | B | 25,8M $US | 2,92 $US | — | 3,4M $US | -691,8 % |
| ENLV | Enlivex Ltd. | non notée | 23,7M $US | 0,49 $US | 0,02 | — | — |
| GRDX | GRIDAI TECHNOLOGIES CORP | F- | 23,5M $US | 3,30 $US | — | 36,3K $US | -56 864,0 % |
| NXTC | NEXTCURE, INC | non notée | 22,4M $US | 4,90 $US | — | — | — |
| COCP | COCRYSTAL PHARMA, INC. | non notée | 21,8M $US | 1,13 $US | — | — | — |
| YARW | YARROW BIOSCIENCE, INC. | C- | 20,6M $US | 23,97 $US | — | 570K $US | -4 646,1 % |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | non notée | 20M $US | 0,46 $US | — | — | — |
| JSPR | JASPER THERAPEUTICS, INC. | non notée | 19,8M $US | 0,60 $US | — | — | — |
| ATOS | ATOSSA THERAPEUTICS, INC. | non notée | 19,7M $US | 1,97 $US | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | non notée | 18,6M $US | 4,93 $US | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | 18,3M $US | 1,10 $US | — | 3,9M $US | -220,5 % |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | non notée | 18,1M $US | 2,82 $US | — | — | — |
| LPCN | LIPOCINE INC. | C- | 17,7M $US | 2,15 $US | — | 1,6M $US | -755,1 % |
| ACTU | Actuate Therapeutics, Inc. | non notée | 17,2M $US | 0,72 $US | — | — | — |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | 17,2M $US | 1,29 $US | — | 7,6M $US | -344,2 % |
| CLRB | Cellectar Biosciences, Inc. | non notée | 17,2M $US | 1,82 $US | — | — | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | 17,1M $US | 0,47 $US | — | 3,8M $US | -200,5 % |
| PTN | PALATIN TECHNOLOGIES, INC. | B- | 16,7M $US | 9,38 $US | — | 13,2M $US | -63,6 % |
| LTGO | Latigo Biotherapeutics, Inc. | non notée | 16,7M $US | 18,10 $US | — | — | — |
| KTTA | PASITHEA THERAPEUTICS CORP. | non notée | 16,4M $US | 0,49 $US | — | — | — |
| BCTX | BRIACELL THERAPEUTICS CORP. | non notée | 16,1M $US | 4,08 $US | — | — | — |
| KZIA | Kazia Therapeutics Limited. | F | 15,8M $US | 9,78 $US | 8,68 | 29,3K $US | -54 287,3 % |
| BCDA | BioCardia, Inc. | F | 15,6M $US | 1,03 $US | — | 0,00 $US | — |
| CTXR | Citius Pharmaceuticals, Inc. | non notée | 15,3M $US | 0,56 $US | — | — | — |
| PASG | PASSAGE BIO, INC. | non notée | 15M $US | 4,67 $US | — | — | — |
| CNSY | CERENOME, INC. | F- | 14,1M $US | 1,86 $US | — | 4,2M $US | -620,7 % |
| HIND | VYOME HOLDINGS, INC. | F- | 14,1M $US | 2,01 $US | — | 129,7K $US | -8 716,8 % |
| LTRN | Lantern Pharma Inc. | non notée | 13,9M $US | 1,09 $US | — | — | — |
| NCEL | NewcelX Ltd. | non notée | 13,7M $US | 2,87 $US | 1,33 | — | — |
| LSTA | LISATA THERAPEUTICS, INC. | C- | 13,1M $US | 1,46 $US | — | 100K $US | -14 621,0 % |
| AEON | AEON Biopharma, Inc. | non notée | 13,1M $US | 0,26 $US | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | 13M $US | 0,29 $US | — | 2,5M $US | -2 702,6 % |
| PLUR | Pluri Inc. | D | 12,8M $US | 1,04 $US | — | 1M $US | -2 344,6 % |
| INAB | IN8BIO, INC. | non notée | 12,8M $US | 1,30 $US | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | 12,5M $US | 0,81 $US | — | 1,4M $US | -804,4 % |
| RADX | Radiopharm Theranostics Limited | F- | 12,2M $US | 1,55 $US | — | 3,6M $US | -1 055,3 % |
| TPST | Tempest Therapeutics, Inc. | non notée | 12,1M $US | 0,82 $US | — | — | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | 11,8M $US | 2,67 $US | — | 0,00 $US | — |
| BIVI | BioVie Inc. | non notée | 11,6M $US | 1,54 $US | — | — | — |
| CMMB | SNOWDRIFT PARENT CORPORATION | non notée | 11,6M $US | 1,61 $US | 89,44 | — | — |
| BLRX | BioLineRx Ltd | C- | 11,3M $US | 2,60 $US | — | 1,2M $US | -171,7 % |
| INTS | INTENSITY THERAPEUTICS, INC. | non notée | 11,2M $US | 3,43 $US | — | — | — |
| MTVA | METAVIA INC. | non notée | 11M $US | 1,67 $US | — | — | — |
| ADIL | Adial Pharmaceuticals, Inc. | non notée | 10,7M $US | 4,09 $US | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | 10,4M $US | 0,53 $US | — | 0,00 $US | — |
| KALA | KALA BIO, INC. | F | 9,8M $US | 0,51 $US | — | 0,00 $US | — |
| TOVX | Theriva Biologics, Inc. | non notée | 9,8M $US | 0,21 $US | — | — | — |
| GDTC | CytoMed Therapeutics Limited | D- | 9,8M $US | 0,83 $US | — | 253,9K $US | -1 227,1 % |
| TRAW | Traws Pharma, Inc. | C- | 9,6M $US | 0,62 $US | — | 2,8M $US | -773,0 % |
| SNTI | Senti Biosciences Holdings, Inc. | F- | 9,5M $US | 0,31 $US | — | 22K $US | -225 290,9 % |
| IMRN | IMMURON LIMITED | D- | 9,5M $US | 1,18 $US | — | 5,1M $US | -71,6 % |
| FBLG | FibroBiologics, Inc. | non notée | 8,9M $US | 1,33 $US | — | — | — |
| ALZN | ALZAMEND NEURO, INC. | non notée | 8,8M $US | 1,83 $US | — | — | — |
| VRAX | Virax Biolabs Group Ltd | C- | 8,2M $US | 2,20 $US | — | 6,3K $US | -95 739,2 % |
| ENSC | ENSYSCE BIOSCIENCES, INC. | D- | 8,2M $US | 0,42 $US | — | 4,5M $US | -280,5 % |
| SNGX | SOLIGENIX, INC. | D- | 7,8M $US | 0,36 $US | — | 119,4K $US | -8 577,8 % |
| CBUS | Cibus, Inc. | C- | 7,8M $US | 1,56 $US | — | 4,3M $US | -2 258,9 % |
| XCUR | EXICURE, INC. | F | 7,5M $US | 1,14 $US | — | 0,00 $US | — |
| IMNN | Imunon, Inc. | non notée | 7,4M $US | 1,32 $US | — | — | — |
| ALLR | Allarity Therapeutics, Inc. | B- | 7,4M $US | 0,97 $US | — | 320K $US | -3 854,4 % |
| ARTL | ARTELO BIOSCIENCES, INC. | non notée | 7,2M $US | 4,15 $US | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | D- | 6,9M $US | 3,58 $US | — | 4,7M $US | -611,5 % |
| ACXP | Acurx Pharmaceuticals, Inc. | non notée | 6,9M $US | 1,31 $US | — | — | — |
| ENVB | ENVERIC BIOSCIENCES, INC. | non notée | 6,6M $US | 1,47 $US | — | — | — |
| CELZ | Creative Medical Technology Holdings, Inc. | D- | 6,2M $US | 0,95 $US | — | 3K $US | -201 355,4 % |
| PULM | PULMATRIX, INC. | B- | 5,9M $US | 1,61 $US | — | 7,8M $US | -51,4 % |
| AGMB | AgomAb Therapeutics NV | non notée | 5,7M $US | 10,46 $US | — | — | — |
| CDIO | Cardio Diagnostics Holdings, Inc. | C- | 5,6M $US | 1,90 $US | — | 14,5K $US | -44 771,8 % |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | 5,4M $US | 2,30 $US | — | 3,3M $US | -75,9 % |
| ERNA | Ernexa Therapeutics Inc. | B- | 5,3M $US | 3,23 $US | — | 582K $US | -2 106,0 % |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | 5,2M $US | 2,20 $US | — | 451K $US | -1 545,2 % |
| PCSA | Processa Pharmaceuticals, Inc. | non notée | 4,9M $US | 1,76 $US | — | — | — |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | 4,8M $US | 1,39 $US | — | 1,5M $US | -558,6 % |
| PHIO | Phio Pharmaceuticals Corp. | non notée | 4,7M $US | 1,03 $US | — | — | — |
| GRI | GRI BIO, INC. | non notée | 4,5M $US | 2,07 $US | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | 4,5M $US | 0,42 $US | — | 0,00 $US | — |
| DRMA | DERMATA THERAPEUTICS, INC. | non notée | 4,5M $US | 1,12 $US | — | — | — |
| QNTM | Quantum BioPharma Ltd. | non notée | 4,3M $US | 3,80 $US | — | — | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | 4,3M $US | 1,21 $US | — | 1,1M $US | -729,9 % |
| OSRH | OSR HEALTH, INC. | D- | 4,1M $US | 0,12 $US | — | 1,8M $US | -824,4 % |
| CVKD | Cadrenal Therapeutics, Inc. | non notée | 3,9M $US | 1,09 $US | — | — | — |
| EVGN | EVOGENE LTD. | D- | 3,5M $US | 0,41 $US | — | 1,3M $US | -649,2 % |
| ADXN | Addex Therapeutics Ltd | D- | 3,5M $US | 2,81 $US | — | 35,9K $US | -22 448,4 % |
| REVB | REVELATION BIOSCIENCES, INC. | non notée | 3,3M $US | 0,84 $US | — | — | — |
| APVO | Aptevo Therapeutics Inc. | non notée | 3,3M $US | 1,82 $US | — | — | — |
| HCWB | HCW Biologics Inc. | B- | 3,3M $US | 1,78 $US | — | 6,7M $US | -83,8 % |
| MBIO | MUSTANG BIO, INC. | non notée | 3,2M $US | 0,48 $US | — | — | — |
| PBM | PSYENCE BIOMEDICAL LTD | non notée | 3M $US | 5,50 $US | — | — | — |
| HLSQ | BiomX Inc. | non notée | 2,8M $US | 0,43 $US | — | — | — |
| SILO | SILO PHARMA, INC. | F- | 2,6M $US | 1,63 $US | — | 54,1K $US | -8 269,5 % |
| GOVX | GEOVAX LABS, INC. | D | 2,6M $US | 0,35 $US | — | 0,00 $US | — |
| TCRT | Alaunos Therapeutics, Inc. | D- | 2,5M $US | 0,97 $US | — | 3K $US | -133 666,7 % |
| GNPX | Genprex, Inc. | D | 2,4M $US | 2,89 $US | — | 0,00 $US | — |
| AZTR | Azitra, Inc. | F- | 2,3M $US | 0,13 $US | — | 0,00 $US | — |
| VBIO | Valion Bio, Inc. | F- | 2,2M $US | 2,98 $US | — | 482K $US | -3 890,0 % |
| OGEN | ORAGENICS, INC. | non notée | 2,2M $US | 0,49 $US | — | — | — |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | 1,9M $US | 2,52 $US | — | 21,8K $US | -42 206,9 % |
| AIM | AIM IMMUNOTECH INC. | D | 1,9M $US | 0,17 $US | — | 95K $US | -15 021,1 % |
| CANF | Can-Fite BioPharma Ltd. | F- | 1,8M $US | 2,18 $US | — | 405K $US | -2 426,7 % |
| SPRC | SCISPARC LTD. | F- | 1,8M $US | 4,84 $US | — | 856K $US | -1 422,8 % |
| CRIS | CURIS, INC. | F- | 1,7M $US | 0,82 $US | — | 4,3M $US | -490,3 % |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | non notée | 1,6M $US | 1,67 $US | — | — | — |
| DCOY | Decoy Therapeutics Inc. | non notée | 1,4M $US | 2,11 $US | — | — | — |
| BBLG | BONE BIOLOGICS CORPORATION | non notée | 1,3M $US | 0,48 $US | — | — | — |
| VIVS | VivoSim Labs, Inc. | D | 1,1M $US | 0,21 $US | — | 112K $US | -11 016,1 % |
| CLDI | Calidi Biotherapeutics, Inc. | non notée | 1,1M $US | 1,05 $US | — | — | — |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | non notée | 1M $US | 0,98 $US | — | — | — |
| QNRX | Quoin Pharmaceuticals Ltd. | non notée | 997,3K $US | 5,68 $US | — | — | — |
| ONCO | Onconetix, Inc. | D- | 949K $US | 0,82 $US | — | 645,8K $US | -1 578,8 % |
| CMND | Clearmind Medicine Inc. | non notée | 920,4K $US | 0,79 $US | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | non notée | 586,2K $US | 0,52 $US | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | non notée | 561,9K $US | 10,99 $US | — | — | — |
| PLRZ | Polyrizon Ltd. | non notée | 488,7K $US | 10,78 $US | 2,20 | — | — |
| CDT | CDT EQUITY INC. | non notée | 441,2K $US | 1,45 $US | — | — | — |
| EDVA | SPLASH BEVERAGE GROUP, INC. | D | 370,9K $US | 0,17 $US | — | 32,1K $US | -53 856,5 % |
| BDRX | Biodexa Pharmaceuticals PLC | non notée | 369,2K $US | 0,67 $US | — | — | — |
| SLXN | SILEXION THERAPEUTICS CORP | non notée | 162,5K $US | 0,32 $US | — | — | — |
| NEUP | Neuphoria Therapeutics Inc. | F- | 108,2K $US | 3,60 $US | — | 1,2M $US | -1 145,7 % |
| KPTI | Karyopharm Therapeutics Inc. | B | 30,7K $US | 1,21 $US | — | 146,6M $US | -153,3 % |
| PPBT | PURPLE BIOTECH LTD. | non notée | 362,44 $US | 1,51 $US | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | non notée | — | 20,64 $US | — | — | — |
| APGE | Apogee Therapeutics, Inc. | non notée | — | 135,07 $US | — | — | — |
| ATAI | AtaiBeckley Inc. | non notée | — | 7,35 $US | — | 4,1M $US | -16 142,0 % |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | 0,74 $US | — | 0,00 $US | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | 84,95 $US | — | 42,2M $US | -1 189,9 % |
| ETRA | Electra Therapeutics, Inc. | non notée | — | 11,35 $US | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | non notée | — | 76,99 $US | — | — | — |
| SLBT | SL Science Holding Limited | non notée | — | 1,83 $US | — | — | — |
| VCRE | Vicore Pharma Holding AB | non notée | — | 9,53 $US | — | — | — |
| VRXA | Veraxa Biotech Holding AG | non notée | — | 1,32 $US | — | — | — |
| VTVT | vTv Therapeutics Inc. | D- | — | 30,01 $US | — | 36,8M $US | -12,9 % |
Fondamentaux issus des documents déposés auprès de la SEC, cours issus de la dernière collecte de données de marché. Triez par n’importe quelle colonne ; les entreprises sans chiffre passent en dernier dans les deux sens.
Trié par capitalisation, de la plus grande à la plus petite ; cliquez sur une colonne pour retrier. Les entreprises sans chiffre passent en dernier dans les deux sens, parce qu’un PER manquant signifie une perte et non un titre bon marché. Rien ici n’est une recommandation.